Truffle Hound Capital LLC acquired a new stake in shares of FONAR Co. (NASDAQ:FONR - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 90,000 shares of the medical equipment provider's stock, valued at approximately $1,363,000. Truffle Hound Capital LLC owned about 1.42% of FONAR at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in the stock. Money Concepts Capital Corp boosted its stake in FONAR by 5.9% in the 4th quarter. Money Concepts Capital Corp now owns 401,577 shares of the medical equipment provider's stock worth $6,080,000 after purchasing an additional 22,245 shares in the last quarter. Peapod Lane Capital LLC bought a new position in shares of FONAR in the fourth quarter worth approximately $2,159,000. Linden Thomas Advisory Services LLC grew its holdings in shares of FONAR by 15.1% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 29,236 shares of the medical equipment provider's stock valued at $443,000 after buying an additional 3,837 shares during the last quarter. Corsair Capital Management L.P. increased its position in shares of FONAR by 8.8% during the third quarter. Corsair Capital Management L.P. now owns 27,972 shares of the medical equipment provider's stock valued at $453,000 after acquiring an additional 2,266 shares in the last quarter. Finally, Empowered Funds LLC raised its holdings in FONAR by 5.1% in the 4th quarter. Empowered Funds LLC now owns 19,635 shares of the medical equipment provider's stock worth $297,000 after acquiring an additional 945 shares during the last quarter. 50.64% of the stock is owned by institutional investors.
FONAR Stock Performance
Shares of FONR traded up $0.41 during mid-day trading on Wednesday, hitting $13.91. 5,930 shares of the company traded hands, compared to its average volume of 16,521. FONAR Co. has a 1 year low of $13.27 and a 1 year high of $22.10. The stock has a 50-day moving average price of $14.99 and a two-hundred day moving average price of $15.49. The stock has a market cap of $86.28 million, a price-to-earnings ratio of 12.10 and a beta of 1.27.
FONAR (NASDAQ:FONR - Get Free Report) last posted its earnings results on Wednesday, February 19th. The medical equipment provider reported $0.29 earnings per share for the quarter. FONAR had a return on equity of 4.94% and a net margin of 7.68%. The company had revenue of $24.95 million for the quarter.
About FONAR
(
Free Report)
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
See Also
Before you consider FONAR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FONAR wasn't on the list.
While FONAR currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
